Deal Summary
Pharma Capital SA (Pharma Capital), part of Morocco's Sefrioui Group, has acquired a stake in Moroccan pharmaceutical group Afric Phar (The Group), comprising stakes in Afric-Phar SA (95.35%), Pharmis SA (55%), and Partner Lab SA (4%). Part of this transaction, the largest in Africa's pharmaceutical sector, involved Pharma Capital acquiring shares from the Chaoui family, former proprietors of Afric-Phar and Pharmis, for an undisclosed sum. Afric-Phar specialises in producing and distributing pharmaceutical products for cardiology, nephrology, nutrition, anaesthesia, respiratory, and central nervous system treatments, while Pharmis focuses on pharmaceutical production and distribution, and Partner Lab specialises in research and development. Oaklins Atlas Capital acted as financial advisor to the Sefrioui Group, DLA Piper provided legal counsel, and Emerge Invest advised on the acquisition.
Terms
- Seller: Mr Driss Mamoun Chaoui (CEO of Afric Phar group) & Chaoui family
- Buyer: Sefrioui Group
- Fund Managers: Pharma Capital SA (part of the Sefrioui Group)
- Target:
